Department of Commerce
Foreign-Trade Zones Board
- [B-25-2020]
On April 29, 2020, Janssen Pharmaceuticals Inc., submitted a notification of proposed production activity to the FTZ Board for its facility within Subzone 26K, in Athens, Georgia.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including ( printed page 54345) notice in the Federal Register inviting public comment (85 FR 27205-27206, May 7, 2020). On August 27, 2020, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: August 27, 2020.
Andrew McGilvray,
Executive Secretary.